Allez à nos transactions
Soins de la Santé | TMT

Medis Medical Imaging and GE HealthCare announce collaboration focused on non-invasive coronary assessments

Medis Medical Imaging Systems B.V., a leading cardiac imaging software company, have completed a strategic investment to further develop its revolutionary non-invasive cardiovascular imaging solution. The company has announced its collaboration with GE HealthCare (Nasdaq: GEHC), a global leader in medical technology, pharmaceutical diagnostics and innovation in digital solutions, to contribute to the advancement of precision care in the diagnosis and treatment of coronary artery disease (CAD).

Founded in 1989, Medis Medical Imaging Systems B.V. provides high-quality quantitative analysis solutions for cardiovascular imaging to the medical community. Medis’ software is internationally appreciated due to its ease of use and clinical outcomes for patients. The company continuously focuses on creating, researching and innovating towards clinically relevant software solutions in the field of cardiovascular imaging.

Oaklins’ team in the Netherlands acted as the exclusive strategic advisor to the shareholders and management of Medis Medical Imaging Systems B.V.

Services
Conseil en financement par dette ou en équité
Parties prenantes
«We are delighted to be taking this next step with GE HealthCare, a fellow leader in the interventional cardiology domain. Building on Medis QFR’s decade of AI research, customer-focused product development, clinical evidence generation and business development, we are excited to be able to further accelerate our efforts around Medis QFR to enable more hospitals and clinicians to apply physiology in day-to-day interventional practice as part of clinical care best practices, making this technology more accessible and available to patients than ever before.»

Maya Barley

CEO, Medis Medical Imaging Systems B.V.

Contacter l'équipe de la transaction

Martijn de Win

Martijn de Win

Directeur
Amsterdam, Pays-Bas
Oaklins Netherlands
Voir le profil Entrer en contact
Robert Boersma

Robert Boersma

Associé
Amsterdam, Pays-Bas
Oaklins Netherlands
Voir le profil Entrer en contact
Robbert Bon

Robbert Bon

Analyste principal
Amsterdam, Pays-Bas
Oaklins Netherlands
Voir le profil Entrer en contact

Transactions connexes

UKAT Group has acquired Bayberry Limited
Placements Privés | Soins de la Santé

UKAT Group has acquired Bayberry Limited

UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.

En apprendre plus
Medicija has acquired Saulės Šeimos Medicinos Centras
Soins de la Santé

Medicija has acquired Saulės Šeimos Medicinos Centras

Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.

En apprendre plus
Quimpharma has completed the divestiture of a product portfolio to Megalabs
Soins de la Santé

Quimpharma has completed the divestiture of a product portfolio to Megalabs

Quimpharma has completed the divestiture of a product portfolio to Megalabs México.

En apprendre plus